Jury awards St. Jude $2.3B in trade secrets case

A California jury has awarded a St. Jude Medical unit $2.3 billion in a verdict against a former employee and the Chinese medical device company he started. It found the defendants liable for stealing trade secrets; the device giant had accused Yongning Zou of downloading confidential technical information from a company database before leaving to start Nervicon. St. Jude maintained Zou wanted to use the data to save hundreds of millions of dollars in research while tapping a $4.6 billion Chinese market for implantable medical devices, according to Law360. News

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.